Back to AVLN

SR ONE CAPITAL MANAGEMENT, LP → AVLN

SR ONE CAPITAL MANAGEMENT, LP AVLN Position History

Avalyn Pharma Inc. • Healthcare

Quarters held
2
Latest value
$94.3M
Q3 2026
Peak value
$108.9M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$108.9M
Q3 2026$94.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$94.3M3.31M——
Q2 2026$108.9M3.31M——

Other funds holding AVLN

Other SR ONE CAPITAL MANAGEMENT, LP positions

MANE

Veradermics, Inc.

$295.3M
MANE

Veradermics, Inc.

$252.2M
ADRX

ADARx Pharmaceuticals, Inc.

$198.1M
ZBIO

Zenas BioPharma, Inc

$182.9M
MANE

Veradermics, Inc.

$151.7M
ZBIO

Zenas BioPharma, Inc

$135.9M
ZBIO

Zenas BioPharma, Inc

$127.9M
CRSP

CRISPR Therapeutics AG

$112.8M